Induction regimens for ANCA-Associated Vasculitis
- PMID: 24195565
- PMCID: PMC4497541
- DOI: 10.1056/NEJMc1311108
Induction regimens for ANCA-Associated Vasculitis
Conflict of interest statement
No potential conflict of interest relevant to this letter was reported.
Comment on
-
Efficacy of remission-induction regimens for ANCA-associated vasculitis.N Engl J Med. 2013 Aug 1;369(5):417-27. doi: 10.1056/NEJMoa1213277. N Engl J Med. 2013. PMID: 23902481 Free PMC article. Clinical Trial.
-
Induction regimens for ANCA-Associated Vasculitis.N Engl J Med. 2013 Nov 7;369(19):1864. doi: 10.1056/NEJMc1311108. N Engl J Med. 2013. PMID: 24195566 No abstract available.
-
Induction Regimens for ANCA-Associated Vasculitis.N Engl J Med. 2013 Nov 7;369(19):1864-5. doi: 10.1056/NEJMc1311108. N Engl J Med. 2013. PMID: 24195567 No abstract available.
References
-
- Harper L, Morgan MD, Walsh M, et al. Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Ann Rheum Dis. 2012;71:955–60. - PubMed
-
- Smith RM, Jones RB, Guerry MJ, et al. Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2012;64:3760–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources